The Biotechnology Innovation Organization (BIO) launched the BIO Investment Council to bridge venture investors and emerging biotech companies, with the stated goal of accelerating capital formation for early‑stage life‑science innovation. The Council will advise BIO on policies affecting investment, help align investors with suitable small biotechs, and feature leaders from both VC and corporate funds. BIO said the council will play an active role in forthcoming BIO events, including the BIO Investor Growth Summit, and will focus on removing barriers to private capital for startups developing next‑generation medicines and technologies.